Literature DB >> 19156418

[Atypical ductal hyperplasia and atypical epithelial proliferation of ductal type].

W Böcker1, D Hungermann, S Weigel, K Roterberg, T Decker.   

Abstract

The definition of atypical ductal hyperplasia (ADH) encompasses qualitative and quantitative criteria. Qualitative criteria include cytological and architectural features similar to those of low grade ductal carcinoma in situ (DCIS), the quantitative criteria are characterized by metric features (2 mm or 2 ductules) or by the confines of lobules. In this article we discuss the morphology of ADH, the status of ADH in the low grade pathway of breast carcinoma development and its clinical significance. Furthermore, we comment some special forms of atypical epithelial proliferations of the ductal type.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156418     DOI: 10.1007/s00292-008-1101-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  22 in total

1.  Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases.

Authors:  T Moriya; K Sakamoto; H Sasano; M Kawanaka; H Sonoo; T Manabe; J Ito
Journal:  Mod Pathol       Date:  2000-01       Impact factor: 7.842

Review 2.  The spectrum of apocrine lesions of the breast.

Authors:  F P O'Malley; A L Bane
Journal:  Adv Anat Pathol       Date:  2004-01       Impact factor: 3.875

3.  Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

Authors:  P O'Connell; V Pekkel; S A Fuqua; C K Osborne; G M Clark; D C Allred
Journal:  J Natl Cancer Inst       Date:  1998-05-06       Impact factor: 13.506

Review 4.  Stereotactic core-needle biopsy of the breast: a report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American Pathologists.

Authors:  L Bassett; D P Winchester; R B Caplan; D D Dershaw; K Dowlatshahi; W P Evans; L L Fajardo; P L Fitzgibbons; D E Henson; R V Hutter; M Morrow; J R Paquelet; S E Singletary; J Curry; P Wilcox-Buchalla; M Zinninger
Journal:  CA Cancer J Clin       Date:  1997 May-Jun       Impact factor: 508.702

5.  LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia.

Authors:  M Amari; A Suzuki; T Moriya; K Yoshinaga; G Amano; H Sasano; N Ohuchi; S Satomi; A Horii
Journal:  Oncol Rep       Date:  1999 Nov-Dec       Impact factor: 3.906

6.  Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology.

Authors:  J P Sloane; I Amendoeira; N Apostolikas; J P Bellocq; S Bianchi; W Boecker; G Bussolati; D Coleman; C E Connolly; V Eusebi; C De Miguel; P Dervan; R Drijkoningen; C W Elston; D Faverly; A Gad; J Jacquemier; M Lacerda; J Martinez-Penuela; C Munt; J L Peterse; F Rank; M Sylvan; V Tsakraklides; B Zafrani
Journal:  Virchows Arch       Date:  1999-01       Impact factor: 4.064

7.  The histologic spectrum of apocrine breast proliferations: a comparative study of morphology and DNA content by image analysis.

Authors:  U Raju; R J Zarbo; J Kubus; D S Schultz
Journal:  Hum Pathol       Date:  1993-02       Impact factor: 3.466

8.  Ductal carcinoma in situ of the breast with apocrine cytology: definition of a borderline category.

Authors:  F P O'Malley; D L Page; E H Nelson; W D Dupont
Journal:  Hum Pathol       Date:  1994-02       Impact factor: 3.466

9.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

10.  Human breast duct anatomy, the 'sick lobe' hypothesis and intraductal approaches to breast cancer.

Authors:  James J Going; Timothy J Mohun
Journal:  Breast Cancer Res Treat       Date:  2006-04-27       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.